Appendix 2: Blood products, their uses, and how long they last
New Zealand Blood Service: Managing the safety and supply of blood products.
Fresh blood products
Medical use | Shelf life | |
---|---|---|
Plasma | For patients after trauma or transplants | Up to two years if stored below –25°C |
Platelets | For patients with some blood diseases or cancer, and to control bleeding after surgery or trauma | Up to five days if stored at 22°C and constantly moved |
Red blood cells | For patients with chronic anaemia resulting from disorders such as kidney failure or cancer, and acute blood loss from trauma or surgery | Up to 35 days when stored at 4°C |
Products manufactured from plasma
Medical use | Shelf life | |
---|---|---|
Albumex®4 | In patients with burns or in shock from blood loss | Up to two years |
Albumex®20 | To treat liver failure or renal failure associated with severe protein deficiency | |
Rh(D) Immunoglobulin-VF (Anti-D) | To prevent haemolytic disease in newborns whose blood type is incompatible with their mother | |
Cryoprecipitate | For helping blood to clot in trauma patients and during cardiac surgery or transplants | |
Biostate® (Factor VIII) | To manage haemophilia A, an inherited bleeding disorder that requires lifelong treatment | |
MonoFIX®-VF (Factor IX) | To treat haemophilia B, an inherited bleeding disorder | |
Prothrombinex-VF (Factors II, IX, and X) |
To reverse the anticoagulant effect of warfarin in bleeding patients | |
Hyperimmune globulins | To temporarily protect from a specific infection, such as tetanus or hepatitis B | |
Intragam®P | To treat patients with immune deficiencies or those whose immune system has been compromised | |
Normal immunoglobulin | To protect travellers from contracting hepatitis A when visiting high-risk areas |
Source: New Zealand Blood Service (2011), New Zealand Blood Service Annual Report 2010/11.
page top